European commercial launch of first approved life-saving treatment for severe hepatic veno-occlusive disease

by | Apr 2, 2014 | News Feeds, Stem Cell Research

Jazz Pharmaceuticals plc and Gentium S.p.A., a Jazz Pharmaceuticals company, have announced the commencement of the European commercial launch of Defitelio®q (defibrotide), the first licensed…